کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2101840 1546263 2015 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation
ترجمه فارسی عنوان
ایجاد تعاریف و بررسی روند برای قضاوت دائمی مرگ و میر ناشی از علت بعد از پیوند سلول های هماتوپوئیدی آلوژنیک غیر مرتبط
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
چکیده انگلیسی


• Clinical scenarios/definitions of cause-specific death after URD-HCT are presented.
• A high rate of agreement was found between reported and adjudicated disease-related deaths.
• A discordance of 20% was found between reported and adjudicated transplant-related deaths.
• Discordance varied among GVHD, infection, organ failure and other causes of death.

Clinical trials commonly use adjudication committees to refine endpoints, but observational research or genome-wide association studies rarely do. Our goals were to establish definitions of cause-specific death after unrelated-donor allogeneic hematopoietic cell transplantation (URD-HCT), to estimate discordance between reported and adjudicated cause-specific death, and to identify factors contributing to inconsistency in cause-specific death determination. A consensus panel adjudicated cause-specific death in 1484 patients who died within 1 year after HCT, derived from 3532 acute leukemia or myelodysplasia patients after URD-HCT from 2000 to 2011 reported by 151 US transplant centers to the Center for International Blood and Marrow Transplant Research. Deaths were classified as disease-related or transplant-related. The panel agreed with >99% of deaths reported by centers as disease-related and 80% reported as transplant-related. Year of transplant (cohort effect) and disease status significantly influenced agreement between the panel and centers. Sensitivity analysis of deaths < 100 days post-transplant yielded the lowest agreement between the panel and centers for myelodysplastic syndrome patients. Standard predefined criteria for adjudicating cause-specific death led to consistent application to similar clinical scenarios and clearer delineation of cause-specific death categories. Other studies of competing events such as cancer-specific versus treatment-related mortality would benefit from our results. Our detailed algorithm should result in more consistent reporting of cause-specific death by centers.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: - Volume 21, Issue 9, September 2015, Pages 1679–1686
نویسندگان
, , , , , , , , , , , , , ,